BEAT Forex ziņas

HeartBeam Submits 510(k) Application To FDA For AIMI Platform Technology To Diagnose Heart Attacks

Digital healthcare company HeartBeam, Inc. (BEAT) announced Tuesday it has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its HeartBeam AIMI Platform Technology for use in diagnosing heart attacks.

RTTNews | 876 days ago

Noteikumi | Privātums | Lapas karte | Site Map Calendar

HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.

EURUSD	1.03081	GBPUSD	1.22888	AUDUSD	0.6194
USDJPY	158.134	USDCAD	1.43846	USDCHF	0.91162